Charles Y. Lin
Biogen (United States)(US)Baylor College of Medicine(US)King Saud Medical City(SA)South Texas Accelerated Research Therapeutics(US)Kronos Bios (United Kingdom)(GB)Baylor Genetics(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, RNA modifications and cancer, Glioma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes(2013)4,272 cited
- → Transcriptional Amplification in Tumor Cells with Elevated c-Myc(2012)1,553 cited
- → c-Myc Regulates Transcriptional Pause Release(2010)1,274 cited
- → Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma(2013)757 cited
- → Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer(2016)621 cited
- → NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis(2014)617 cited